Back
Neumora Therapeutics, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
31
NMRA
Neumora Therapeutics, Inc.
Last Price:
$1.78
Seasonality Move:
-24.63%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NMRA is experiencing slight buying pressure.
Neumora Therapeutics, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.77 | Buy |
| 20-day SMA: | 2 | Sell |
| 50-day SMA: | 2.29 | Sell |
| 200-day SMA: | 1.5 | Buy |
| 8-day EMA: | 1.81 | Sell |
| 20-day EMA: | 1.96 | Sell |
| 50-day EMA: | 2.09 | Sell |
| 200-day EMA: | 2.65 | Sell |
Neumora Therapeutics, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 35.76 | Sell |
| Chaikin Money Flow: | 168325 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.83 - 2.27) | Sell |
| Bollinger Bands (100): | (1.58 - 2.4) | Sell |
Neumora Therapeutics, Inc. Technical Analysis
| Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | Dec 24 | Dec 26 | Dec 29 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 26 | 29 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Neumora Therapeutics, Inc. Stock
Is Neumora Therapeutics, Inc. Stock a Buy?
-
Neumora Therapeutics, Inc. share price is 1.78 while NMRA 8-day simple moving average is 1.77, which is a Buy signal.
-
The stock price of NMRA is 1.78 while Neumora Therapeutics, Inc. 20-day SMA is 2.00, which makes it a Sell.
-
Neumora Therapeutics, Inc. 50-day simple moving average is 2.29 while NMRA share price is 1.78, making it a Sell technically.
-
NMRA stock price is 1.78 and Neumora Therapeutics, Inc. 200-day simple moving average is 1.50, creating a Buy signal.
NMRA Technical Analysis vs Fundamental Analysis
Sell
31
Neumora Therapeutics, Inc. (NMRA)
is a Sell
Is Neumora Therapeutics, Inc. a Buy or a Sell?
-
Neumora Therapeutics, Inc. stock is rated a SellThe current Neumora Therapeutics, Inc. [NMRA] share price is $1.78. The Score for NMRA is 31, which is 38% below its historic median score of 50, and infers higher risk than normal.
Neumora Therapeutics, Inc. Stock Info
Market Cap:
297.4M
Price in USD:
1.78
Share Volume:
675.8K
Neumora Therapeutics, Inc. 52-Week Range
52-Week High:
11.51
52-Week Low:
0.61
Sell
31
Neumora Therapeutics, Inc. (NMRA)
is a Sell
Neumora Therapeutics, Inc. Share Price Forecast
-
What is the Neumora Therapeutics, Inc. stock price today?The Neumora Therapeutics, Inc. stock price is 1.78 USD today.
-
Will NMRA stock go up or go down?Neumora Therapeutics, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Neumora Therapeutics, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Neumora Therapeutics, Inc. is overvalued.
Is Neumora Therapeutics, Inc. Stock a Buy?
-
Neumora Therapeutics, Inc. share price is 1.78 while NMRA 8-day exponential moving average is 1.81, which is a Sell signal.
-
The stock price of NMRA is 1.78 while Neumora Therapeutics, Inc. 20-day EMA is 1.96, which makes it a Sell.
-
Neumora Therapeutics, Inc. 50-day exponential moving average is 2.09 while NMRA share price is 1.78, making it a Sell technically.
-
NMRA stock price is 1.78 and Neumora Therapeutics, Inc. 200-day simple moving average is 2.65, creating a Sell signal.
Fundamental Analysis of Neumora Therapeutics, Inc.
Is Neumora Therapeutics, Inc. a good investment?
-
Analysts estimate an earnings increase this quarter of $0.07 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.40 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Neumora Therapeutics, Inc.
Should I short Neumora Therapeutics, Inc. stock?
-
NMRA Moving Average Covergence Divergence (MACD) indicator is -0.15, suggesting Neumora Therapeutics, Inc. is a Sell
-
Neumora Therapeutics, Inc. Relative Strength Index (RSI) is 35.76, which suggest Neumora Therapeutics, Inc. is oversold
-
The Bollinger Bands (25) for Neumora Therapeutics, Inc. is (1.83 - 2.27), which suggest Neumora Therapeutics, Inc. is a Sell
-
The Bollinger Bands (100) for Neumora Therapeutics, Inc. is (1.58 - 2.4), which suggest Neumora Therapeutics, Inc. is a Sell
* Neumora Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.